Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Bayer Ag (BAYRY.PK)

Bayer Wins FDA Priority Review For Kerendia In Chronic Kidney Disease With Type 1 Diabetes 5/21/2026 3:16:16 AM

FDA Grants Priority Review For Bayer’s Kerendia In Type 1 Diabetes With CKD 5/21/2026 2:44:54 AM

Bayer Granted Priority Review For Asundexian In Secondary Stroke Prevention 5/19/2026 5:01:42 AM

Bayer Gets FDA Priority Review For Hyrnuo In First-Line HER2-Mutated Lung Cancer 5/18/2026 9:21:31 AM

Bayer: FDA Grants Priority Review For Sevabertinib Lung Cancer Treatment 5/18/2026 9:02:27 AM

Bayer Q1 Profit Jumps; Confirms Full-Year Outlook At Constant Currencies 5/12/2026 2:23:29 AM

Bayer Q1 EPS EUR 2.81; Core EPS EUR 2.71 5/12/2026 1:43:38 AM

Bayer To Acquire Perfuse Therapeutics; Expands Ophthalmology Pipeline 5/6/2026 2:56:56 AM

Bayer To Acquire Perfuse Therapeutics In $2.45 Bln Deal 5/6/2026 2:37:05 AM

Evotec Nominates Dieter Weinand As Supervisory Board Chairman 4/7/2026 1:58:22 AM

Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS 4/3/2026 5:10:06 AM

Bayer Announces Approval Of New Indication For Kerendia In The EU 3/30/2026 2:58:20 AM

Bayer: Kerendia Approved In EU For New Indication In Adult Heart Failure Patients With LVEF =40% 3/30/2026 2:46:26 AM

Formycon Announces Settlement And License Deal With Regeneron And Bayer For Biosimilar FYB203 3/19/2026 1:39:40 AM

Bayer's Finerenone Meets Primary Endpoint In Phase 3 Study For Non-Diabetic Chronic Kidney Disease 3/16/2026 6:51:27 AM

Bayer Q4 Loss Widens On Litigation Charges, Weak Sales; Warns On FY26 3/4/2026 2:12:30 AM

Bayer Q4 Loss Per Share EUR 0.34; Core EPS EUR 1.05 3/4/2026 1:32:42 AM

Older Articles

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap